Provider Guidance: Monitoring, Adjustment, and Eligibility Assessment A qualified healthcare provider evaluates baseline health status, contraindications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2), and current medications before recommending tirzepatide
Bottom line on oral bioavailability: The expectation based on peptide pharmacokinetics is that the majority of intact TB-500 is degraded in the GI tract before reaching systemic circulation
Although it has been approved and prescribed in Spain since 2017, its fame seems to have exploded in recent months, leading to shortages and peoples obsession with getting their hands on the precious injections
I feel amazing, I hit my goal weight in November 2021 just before Thanksgiving
PMID: 40181096 Acta Biochim Biophys Sin (Shanghai) Evolution of GCGR family ligand-receptor extensive cross-interaction systems suggests a therapeutic direction for hyperglycemia in mammals
gratefully acknowledges support from NIH GM066099